United States Department of Transportation
i
Evidence Report: Chronic Kidney Disease and Commercial Motor Vehicle Driver Safety
-
2007-11-05
[PDF-4.10 MB]
Details:
-
Creators:
-
Corporate Creators:
-
Corporate Contributors:
-
Subject/TRT Terms:
-
DOI:
-
Resource Type:
-
Corporate Publisher:
-
NTL Classification:NTL-SAFETY AND SECURITY-Human Factors;NTL-FREIGHT-FREIGHT;NTL-SAFETY AND SECURITY-SAFETY AND SECURITY;NTL-FREIGHT-Trucking Industry;
-
Abstract:The purpose of this evidence report is to address several key questions posed by the Federal Motor Carrier Safety Administration (FMCSA). FMCSA developed each of these key questions so that the answers will provide information useful in updating its current medical examination guidelines. The four key questions addressed in this evidence report are: Key Question 1: Are individuals with kidney disease at an increased risk for a motor vehicle crash? Key Question 2: Are medications used to treat individuals with kidney disease associated with an increased risk of motor vehicle crash among pre-dialysis patients? Key Question 3: Are dialysis and accompanying drug treatments associated with an increased risk of motor vehicle crash? Key Question 4: Are kidney transplantation and accompanying drug treatments associated with an increased crash risk?
-
Format:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
